Akero Therapeutics Inc (AKRO)
22.13
+2.47
(+12.56%)
USD |
NASDAQ |
May 06, 16:00
22.13
0.00 (0.00%)
After-Hours: 20:00
Akero Therapeutics Shareholders Equity (Quarterly): 535.31M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 535.31M |
| September 30, 2023 | 583.14M |
| June 30, 2023 | 616.44M |
| March 31, 2023 | 306.34M |
| December 31, 2022 | 326.56M |
| September 30, 2022 | 343.51M |
| June 30, 2022 | 148.37M |
| March 31, 2022 | 146.54M |
| December 31, 2021 | 169.11M |
| September 30, 2021 | 198.63M |
| June 30, 2021 | 220.13M |
| Date | Value |
|---|---|
| March 31, 2021 | 246.02M |
| December 31, 2020 | 258.71M |
| September 30, 2020 | 286.46M |
| June 30, 2020 | 103.66M |
| March 31, 2020 | 118.32M |
| December 31, 2019 | 128.73M |
| September 30, 2019 | 143.38M |
| June 30, 2019 | 158.39M |
| March 31, 2019 | 69.66M |
| December 31, 2018 | -49.92M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
103.66M
Minimum
Jun 2020
616.44M
Maximum
Jun 2023
265.14M
Average
220.13M
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 405.33M |
| 89bio Inc | 536.31M |
| Viking Therapeutics Inc | 933.89M |
| Eli Lilly and Co | 12.81B |
| Ionis Pharmaceuticals Inc | 386.69M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 580.27M |
| Total Liabilities (Quarterly) | 44.96M |